(Q40773230)

English

Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C (English)

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Daniel J Sikkema

1

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Nancy A Ziembiec

2

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Thomas R Jones

3

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Stephen W Hildreth

4

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Dace V Madore

5

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Sally A Quataert

6

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

12

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

1

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

218-223

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Pneumococcal vaccines: do they prevent infection and how?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Evolution of conjugate vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Pneumococcal Vaccination and Revaccination of Older Adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Human IgG subclass measurements in the clinical laboratory.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Mechanisms of host defense against infection with Streptococcus pneumoniae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Serotypes of Streptococcus pneumoniae Causing Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

24 September 2017

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

17 June 2018

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

17 June 2018

Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

19 August 2018

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

19 August 2018

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=540223

19 August 2018

Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of monoclonal antibodies to quantify subclasses of human IgG. I. Development of two-site immunoenzymometric assays for total IgG subclass determinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15643011

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CDLI.12.1.218-223.2005

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40773230&oldid=1507175467"